Simian immunodeficiency virus-induced changes in T cell cytokine responses in cynomolgus macaques with latent Mycobacterium tuberculosis infection are associated with timing of reactivation

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3527-3537

  Mattila, Joshua T ^a   Diedrich, Collin R ^a   Ling Lin, Philana ^b   Phuah, Jiayao ^a   Flynn, JoAnne L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; LATENT TUBERCULOSIS; MACACA; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIREMIA;

ACUTE DISEASE; ANIMALS; COMORBIDITY; CYTOKINES; GRANULOMA; LATENT TUBERCULOSIS; MACACA FASCICULARIS; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 79953209317     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003773     Document Type: Article

References (53)

1. Selwyn, P. A., P. Alcabes, D. Hartel, D. Buono, E. E. Schoenbaum, R. S. Klein, K. Davenny, and G. H. Friedland. 1992. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N. Engl. J. Med. 327: 1697-1703.
2. Cardona, P. J., and J. Ruiz-Manzano. 2004. On the nature of Mycobacterium tuberculosis-latent bacilli. Eur. Respir. J. 24: 1044-1051.
3. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320: 545-550.
4. Wolday, D., B. Hailu, M. Girma, E. Hailu, E. Sanders, and A. L. Fontanet. 2003. Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians. Ethiop. Med. J. 41 (Suppl 1): 67-73.
5. Djoba Siawaya, J. F., M. Ruhwald, J. Eugen-Olsen, and G. Walzl. 2007. Correlates for disease progression and prognosis during concurrent HIV/TB infection. Int. J. Infect. Dis. 11: 289-299.
6. Lawn, S. D., and G. Churchyard. 2009. Epidemiology of HIV-associated tuberculosis. Curr. Opin. HIV AIDS 4: 325-333.
7. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
8. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Schreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2: 561-572.
9. Keane, J., S. Gershon, R. P. Wise, E. Mirabile-Levens, J. Kasznica, W. D. Schwieterman, J. N. Siegel, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345: 1098-1104.
10. Newport, M. J., C. M. Huxley, S. Huston, C. M. Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941-1949.
11. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
12. Li-Weber, M., and P. H. Krammer. 2003. Regulation of IL4 gene expression by T cells and therapeutic perspectives. Nat. Rev. Immunol. 3: 534-543.
13. Bogdan, C., Y. Vodovotz, J. Paik, Q.W. Xie, and C. Nathan. 1994. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukoc. Biol. 55: 227-233.
14. Mazzarella, G., A. Bianco, F. Perna, D. D'Auria, E. Grella, E. Moscariello, and A. Sanduzzi. 2003. T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clin. Exp. Immunol. 132: 283-288.
15. Boussiotis, V. A., E. Y. Tsai, E. J. Yunis, S. Thim, J. C. Delgado, C. C. Dascher, A. Berezovskaya, D. Rousset, J. M. Reynes, and A. E. Goldfeld. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105: 1317-1325.
16. Djoba Siawaya, J. F., N. Beyers, P. van Helden, and G. Walzl. 2009. Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis. Clin. Exp. Immunol. 156: 69-77.
17. Manca, C., M. B. Reed, S. Freeman, B. Mathema, B. Kreiswirth, C. E. Barry, III, and G. Kaplan. 2004. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 72: 5511-5514.
18. Ordway, D. J., L. Costa, M. Martins, H. Silveira, L. Amaral, M. J. Arroz, F. A. Ventura, and H. M. Dockrell. 2004. Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J. Infect. Dis. 190: 756-766.
19. de la Barrera, S., M. Aleman, R. Musella, P. Schierloh, V. Pasquinelli, V. Garcia, E. Abbate, and Mdel. C. Sasiain. 2004. IL-10 down-regulates costimulatory molecules on Mycobacterium tuberculosis-pulsed macrophages and impairs the lytic activity of CD4 and CD8 CTL in tuberculosis patients. Clin. Exp. Immunol. 138: 128-138.
20. Green, A. M., J. T. Mattila, C. Bigbee, K. S. Bongers, P. L. Lin, and J. L. Flynn. 2010. CD4(+) regulatory T cells in a cynomolgus macaque model of Mycobacterium tuberculosis Infection. J. Infect. Dis. 202: 533-541.
21. Scott-Browne, J. P., S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota, J. D. Fontenot, A. Y. Rudensky, M. J. Bevan, and K. B. Urdahl. 2007. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204: 2159-2169.
22. Makedonas, G., and M. R. Betts. 2006. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. Springer Semin. Immunopathol. 28: 209-219.
23. Ahmed, N., and S. Gottschalk. 2009. How to design effective vaccines: lessons from an old success story. Expert Rev. Vaccines 8: 543-546.
24. Sáez-Cirión, A., G. Pancino, M. Sinet, A. Venet, O. Lambotte; ANRS EP36 HIV Controllers study group. 2007. HIV controllers: how do they tame the virus? Trends Immunol. 28: 532-540.
25. Bolton, D. L., and M. Roederer. 2009. Flow cytometry and the future of vaccine development. Expert Rev. Vaccines 8: 779-789.
26. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789. (Pubitemid 43882629)
27. Marcondes, M. C., M. C. Penedo, C. Lanigan, D. Hall, D. D. Watry, M. Zandonatti, and H. S. Fox. 2006. Simian immunodeficiency virus-induced CD4+ T cell deficits in cytokine secretion profile are dependent on monkey origin. Viral Immunol. 19: 679-689.
28. Caccamo, N., G. Guggino, S. A. Joosten, G. Gelsomino, P. Di Carlo, L. Titone, D. Galati, M. Bocchino, A. Matarese, A. Salerno, et al. 2010. Multifunctional CD4(+)T cells correlate with active Mycobacterium tuberculosis infection. Eur. J. Immunol. 40: 2211-2220.
29. Sutherland, J. S., I. M. Adetifa, P. C. Hill, R. A. Adegbola, and M. O. Ota. 2009. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur. J. Immunol. 39: 723-729.
30. Sutherland, J. S., J. M. Young, K. L. Peterson, B. Sanneh, H. C. Whittle, S. L. Rowland-Jones, R. A. Adegbola, A. Jaye, and M. O. Ota. 2010. Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J. Immunol. 184: 6537-6544.
31. Sutherland, J. S., B. C. de Jong, D. J. Jeffries, I. M. Adetifa, and M. O. Ota. 2010. Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 5: e12365.
32. Day, C. L., N. Mkhwanazi, S. Reddy, Z. Mncube, M. van der Stok, P. Klenerman, and B. D. Walker. 2008. Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J. Infect. Dis. 197: 990-999.
33. Kalsdorf, B., T. J. Scriba, K. Wood, C. L. Day, K. Dheda, R. Dawson, W. A. Hanekom, C. Lange, and R. J. Wilkinson. 2009. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am. J. Respir. Crit. Care Med. 180: 1262-1270.
34. Jalapathy, K. V., C. Prabha, and S. D. Das. 2004. Correlates of protective immune response in tuberculous pleuritis. FEMS Immunol. Med. Microbiol. 40: 139-145.
35. Marchant, A., A. Amedei, A. Azzurri, J. Vekemans, M. Benagiano, C. Tamburini, C. Lienhardt, T. Corrah, K. P. McAdam, S. Romagnani, et al. 2001. Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. Am. J. Respir. Cell Mol. Biol. 24: 187-194.
36. Caccamo, N., S. Meraviglia, F. Dieli, A. Romano, L. Titone, and A. Salerno. 2005. Th0 to Th1 switch of CD4 T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successful therapy: lack of involvement of epitope repertoire and HLA-DR. Immunol. Lett. 98: 253-258.
37. Dieli, F., M. Singh, R. Spallek, A. Romano, L. Titone, G. Sireci, G. Friscia, C. Di Sano, D. Santini, A. Salerno, and J. Ivanyi. 2000. Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand. J. Immunol. 52: 96-102.
38. Wilkinson, R. J., H. M. Vordermeier, K. A. Wilkinson, A. Sjölund, C. Moreno, G. Pasvol, and J. Ivanyi. 1998. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 178: 760-768.
39. Lin, P. L., M. Rodgers, L. Smith, M. Bigbee, A. Myers, C. Bigbee, I. Chiosea, S. V. Capuano, C. Fuhrman, E. Klein, and J. Flynn. 2009. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77: 4631-4642.
40. Diedrich, C. R., J. T. Mattila, E. Klein, C. Janssen, J. Phuah, T. J. Sturgeon, R. C. Montelaro, P. L. Lin, and J. L. Flynn. 2010. Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load. PLoS ONE 5: e9611.
41. Capuano, S. V., III, D. A. Croix, S. Pawar, A. Zinovik, A. Myers, P. L. Lin, S. Bissel, C. Fuhrman, E. Klein, and J. L. Flynn. 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71: 5831-5844.
42. Pawar, S. N., J. T. Mattila, T. J. Sturgeon, P. L. Lin, O. Narayan, R. C. Montelaro, and J. L. Flynn. 2008. Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques. AIDS Res. Hum. Retroviruses 24: 643-654.
43. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek, M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
44. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19: 683-765.
45. Alberghini, M., G. Pasquinelli, L. Zanella, P. Bacchini, and F. Bertoni. 2004. Desmoplastic fibroblastoma: a light and ultrastructural description of two cases. Ultrastruct. Pathol. 28: 149-157.
46. Seder, R. A., P. A. Darrah, and M. Roederer. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8: 247-258.
47. Dlugovitzky, D., A. Torres-Morales, L. Rateni, M. A. Farroni, C. Largacha, O. Molteni, and O. Bottasso. 1997. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol. Med. Microbiol. 18: 203-207.
48. Lawn, S. D., and R. J. Wilkinson. 2010. Primate model to study reactivation of TB associated with retroviral infection. Future Virol 5: 391-395.
49. Stacey, A. R., P. J. Norris, L. Qin, E. A. Haygreen, E. Taylor, J. Heitman, M. Lebedeva, A. DeCamp, D. Li, D. Grove, et al. 2009. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83: 3719-3733.
50. Geldmacher, C., A. Schuetz, N. Ngwenyama, J. P. Casazza, E. Sanga, E. Saathoff, C. Boehme, S. Geis, L. Maboko, M. Singh, et al. 2008. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J. Infect. Dis. 198: 1590-1598.
51. Kaufmann, D. E., and B. D. Walker. 2009. PD-1 and CTLA-4 inhibitory cosignaling pathways in HIV infection and the potential for therapeutic intervention. J. Immunol. 182: 5891-5897.
52. Trautmann, L., L. Janbazian, N. Chomont, E. A. Said, S. Gimmig, B. Bessette, M. R. Boulassel, E. Delwart, H. Sepulveda, R. S. Balderas, et al. 2006. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12: 1198-1202.
53. Einarsdottir, T., E. Lockhart, and J. L. Flynn. 2009. Cytotoxicity and secretion of gamma interferon are carried out by distinct CD8 T cells during Mycobacterium tuberculosis infection. Infect. Immun. 77: 4621-4630.